The vector of anti-TEM8 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human TEM8. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-TEM8 antibody linked to FcεRIγ signaling domains. And the vector product was designed for cell therapy that targets tumor vasculature, including the tumor vascular bed, for example, glioma and breast cancer.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|CAR-T-1-L343-Z||Anti-TEM8 scFv h(CD3ζ) CART, pCDCAR1|
|CAR-T-2-L343-2G||Anti-TEM8 scFv h(CD28-FcεRIγ) CART, pCDCAR1|
|VP-CAR-LC477||Lenti-TEM8 CAR (scFv-CD28-CD3ζ, SB5) Viral Particle|
|CAR-T-2-L343-BZ||Anti-TEM8 scFv h(41BB-CD3ζ) CART, pCDCAR1|
|CAR-T-2-L343-4G||Anti-TEM8 scFv h(CD4-FcεRIγ) CART, pCDCAR1|
|VP-CAR-LC484||Lenti-TEM8 CAR (scFv-CD28-OX40-CD3ζ, SB5) Viral Particle|
|VP-CAR-LC479||Lenti-TEM8 CAR (scFv-CD4-CD3ζ, SB5) Viral Particle|
|CAR-T-2-L343-CZ||Anti-TEM8 scFv h(b2c-CD3ζ) CART, pCDCAR1|
|CAR-T-3-L343-2XZ||Anti-TEM8 scFv h(CD28-OX40-CD3ζ) CART, pCDCAR1|
|VP-CAR-LC478||Lenti-TEM8 CAR (scFv-CD4-FcεRIγ, SB5) Viral Particle|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved